While Globus Medical Inc has underperformed by -4.82%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GMED rose by 69.26%, with highs and lows ranging from $94.93 to $49.33, whereas the simple moving average jumped by 19.65% in the last 200 days.
On January 10, 2025, BofA Securities Upgraded Globus Medical Inc (NYSE: GMED) to Neutral. A report published by Morgan Stanley on December 02, 2024, Upgraded its rating to ‘Overweight’ for GMED. Wells Fargo also Upgraded GMED shares as ‘Overweight’, setting a target price of $78 on the company’s shares in a report dated August 07, 2024. Piper Sandler May 20, 2024d the rating to Overweight on May 20, 2024, and set its price target from $60 to $80. BTIG Research March 18, 2024d its ‘Neutral’ rating to ‘Buy’ for GMED, as published in its report on March 18, 2024. ROTH MKM’s report from October 20, 2023 suggests a price prediction of $75 for GMED shares, giving the stock a ‘Buy’ rating. Stifel also rated the stock as ‘Buy’.
Analysis of Globus Medical Inc (GMED)
Further, the quarter-over-quarter increase in sales is 63.10%, showing a positive trend in the upcoming months.
One of the most important indicators of Globus Medical Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 2.22% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.64, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and GMED is recording 1.09M average volume. On a monthly basis, the volatility of the stock is set at 2.61%, whereas on a weekly basis, it is put at 3.73%, with a loss of -5.55% over the past seven days. Furthermore, long-term investors anticipate a median target price of $97.92, showing growth from the present price of $87.95, which can serve as yet another indication of whether GMED is worth investing in or should be passed over.
How Do You Analyze Globus Medical Inc Shares?
The Medical Devices market is dominated by Globus Medical Inc (GMED) based in the USA. When comparing Globus Medical Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 132.67, there is a growth in quarterly earnings of 4214.94%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 17.22%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 79.76% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GMED shares are owned by institutional investors to the tune of 79.76% at present.
